Reduced effectiveness of repeat influenza vaccination: distinguishing among within-season waning, recent clinical infection, and subclinical infection.

immunogenicity infection block hypothesis infection history influenza test negative design vaccine waning vaccine protection

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
30 Apr 2024
Historique:
received: 27 09 2023
revised: 15 04 2024
accepted: 25 04 2024
medline: 30 4 2024
pubmed: 30 4 2024
entrez: 30 4 2024
Statut: aheadofprint

Résumé

Studies have reported that prior-season influenza vaccination is associated with higher risk of clinical influenza infection among vaccinees. This effect might arise from incomplete consideration of within-season waning and recent infection. Using data from the US Flu Vaccine Effectiveness (VE) Network (2011-2012 to 2018-2019 seasons), we found that repeat vaccinees were vaccinated earlier in a season by one week. After accounting for waning VE, repeat vaccinees were still more likely to test positive for A(H3N2) (OR=1.11, 95%CI:1.02-1.21) but not for influenza B or A(H1N1). We found that clinical infection influenced individuals' decision to vaccinate in the following season while protecting against clinical infection of the same (sub)type. However, adjusting for recent clinical infections did not strongly influence the estimated effect of prior-season vaccination. In contrast, we found that adjusting for subclinical infection could theoretically attenuate this effect. Additional investigation is needed to determine the impact of subclinical infections on VE.

Identifiants

pubmed: 38687898
pii: 7660490
doi: 10.1093/infdis/jiae220
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Investigateurs

Kempapura Murthy (K)
Chandni Raiyani (C)
Kayan Dunnigan (K)
Muffadal Mamawala (M)
Jessie R Chung (JR)
Manish Patel (M)
Lois Lamerato (L)
Michael L Jackson (ML)
C Hallie Phillips (CH)
Erika Kiniry (E)
Edward A Belongia (EA)
Jennifer P King (JP)
Arnold S Monto (AS)
Richard K Zimmerman (RK)
Mary Patricia Nowalk (MP)
Krissy Moehling Geffel (KM)

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For commercial re-use, please contact reprints@oup.com for reprints and translation rights for reprints. All other permissions can be obtained through our RightsLink service via the Permissions link on the article page on our site—for further information please contact journals.permissions@oup.com.

Auteurs

Qifang Bi (Q)

University of Chicago, Chicago, Illinois, USA.

Barbra A Dickerman (BA)

Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Huong Q Nguyen (HQ)

Center for Clinical Epidemiology & Population Health, Marshfield Clinic Research Institute, Marshfield, Wisconsin, USA.

Emily T Martin (ET)

University of Michigan School of Public Health, Ann Arbor, Michigan, USA.

Manjusha Gaglani (M)

Baylor Scott & White Health, Temple, Texas, USA.
Texas A&M University College of Medicine, Temple, Texas, USA.

Karen J Wernli (KJ)

Kaiser Permanente Bernard J. Tyson School of Medicine, Seattle, Washington, USA.

G K Balasubramani (GK)

University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.

Brendan Flannery (B)

National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Marc Lipsitch (M)

Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.

Sarah Cobey (S)

University of Chicago, Chicago, Illinois, USA.

Classifications MeSH